drugset / Trial / NCT00139932

Tiotropium Bromide Alone vs Tiotropium Bromide and Formoterol Fumarate in Subjects With COPD (Study P04272)

NCT00139932 ↗

RandomizedParallel-groupDouble-blindTreatment

Summary

This study is being conducted to determine if the co-administration of formoterol fumarate and tiotropium bromide is more effective than the use of tiotropium bromide alone in patients with COPD.

Timeline

Start
2005-09-01
Primary completion
2006-11-21
Completion
2006-11-21

Outcome

Met primary endpoint

paper At endpoint, FEV(1) AUC(0-4h) increased 340 mL with FORM + TIO versus 170 mL with TIO (p < 0.001). PMID 19229704 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Formoterol Other / unclassified 12 ug —